A close monitoring of virological and immunological hepatitis B markers can improve the diagnosis of HBV reactivation in HBsAg-negative/anti-HBc-positive patients with oncohematological diseases. (February 2019) - Salpini, R.; Cerva, C.; Battisti, A.; Piermatteo, L.; Sacco, A.; Malagnino, V.; Arcese, W.; Cantonetti, M.; Ceccherini-Silberstein, F.; Perno, C.F.; Andreoni, M.; Sarmati, L.; et al.